Company Biocept Inc Nasdaq
Equities
US09072V2043
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Commercial
99.1
%
| 61 | 99.5 % | 26 | 99.1 % | -57.96% |
Development Services
0.9
%
| 0 | 0.2 % | 0 | 0.9 % | +63.27% |
Kits and Specimen Collection Tubes (SCT)
0.0
%
| 0 | 0.3 % | 0 | 0.0 % | -98.83% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 61 | 100.0 % | 26 | 100.0 % | -57.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Barbara Blouw
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/19 |
Nathaniel Sweed
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 60 | 07/03/22 | |
Darrell Taylor
CMP | Compliance Officer | 59 | 09/02/22 |
Robert Walsh
AUD | Comptroller/Controller/Auditor | 31 | 30/04/22 |
David Karlander
PRN | Corporate Officer/Principal | - | 02/08/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,626,026 | 2,626,006 ( 100.00 %) | 0 | 100.00 % |
Stock B | 0 | 2,090 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-4.52% | 12.32B | |
-4.76% | 8.1B | |
+8.43% | 5.87B | |
+28.39% | 5.52B | |
-6.28% | 4.29B | |
-52.84% | 3.16B | |
+12.93% | 2.72B | |
-2.21% | 2.37B | |
+28.84% | 2.23B |